GlassScriptPhysician profile
Jerrold R Zeitels
NPI 1457371957
$2,407.28
in general payments reported to CMS, 2019-2025
13 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,552 · 2020: $73.46 · 2021: $84.75 · 2022: $239 · 2023: $50.11 · 2024: $59.68 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $235 · Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $234.59 |
| Food and Beverage | $223.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $1,490.00 | 2019 | |
| Integra Lifesciences Corporation | $240.31 | 2025 | Micromatrix, Cytal, Integra |
| Organogenesis INC. | $140.47 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $118.45 | 2020-2025 | |
| Lifenet Health | $89.04 | 2025 | Theragenesis Wound Matrix |
| Smith+Nephew, INC. | $81.21 | 2019-2023 | Regranex, Collagenase Santyl |
| Solventum Corporation | $59.68 | 2024 | Prevena, Activ.A.C. |
| Polarityte, INC. | $58.99 | 2019-2020 | |
| Allergan, INC. | $54.19 | 2021 | |
| Kerecis Limited | $27.51 | 2022 | |
| Acera Surgical, INC. | $19.90 | 2023 | Restrata Wound Matrix |
| Axogen | $17.00 | 2023 | Avance Nerve Graft |
| Acell, INC. | $10.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerrold Zeitels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.